Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6]

• Catalog Number: orb1274613
• Category: Antibodies
• Description: Recombinant SARS-CoV-2 (COVID-19) Nucleocapsid ScFv-Fc Antibody [4A6]
• Species/Host: Human
• Clonality: Recombinant
• Clone Number: 4A6
• Tested applications: ELISA
• Reactivity: Virus
• Isotype: Human IgG1
• Immunogen: full length recombinant Nucleocapsid Protein
• Concentration: 5.0 mg/ml (+/- 10 %)
• Dilution range: Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.
• Form/Appearance: Liquid
• Conjugation: Unconjugated
• Target: N
• UniProt ID: P0DTC9
• NCBI: QHD43423
• Storage: 24 months from manufacturing at < -20 °C; 1 month, 2 to 8 °C under sterile conditions.
• Buffer/Preservatives: PBS, pH 7.4
• Alternative names: SARS-CoV-2 (COVID-19) Nucleocapsid Antibody: Sever
• Note: For research use only
• Application notes: Immunoreactivity: 80-120 % compared to the reference sample in an ELISA test.
• Expiration Date: 12 months from date of receipt.

Immobilized 2019-nCoV Nucleocapsid Protein (Cat#orb1228242) at 5.0μg/ml (100μL/well) can bind Recombinant anti-2019-nCoV NP ScFv (4A6), the EC50 is less than 6.65ng/ml.

Stability is confirmed by binding ability with 2019-nCoV Nucleocapsid Protein (Cat#orb1228242). The result showed that product bioactivity is no significant differences among these samples.

Please note that pair recommendations are based on results obtained by our laboratory. Equally good results may be obtained using other pairs and therefore these recommendations are only indicative.

Freeze-thaw stability is tested by repeated freeze-thaw cycles. The result showed that product bioactivity is no significant differences after freeze-thawing 14 times.